About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
LLY - Eli Lilly and Compan...| Previous Close | $190.61 | Open | |
| Volume | 398 | Market Cap | 181.489B |
| Yield | 1.61 % | Last Dividend | $3.05 |
| Novel Approach to Cancer From Lixte Biot... | 04/20/21 |
| The following article is sponsored by Lixte Biotechnology Holdings, Inc. The information contained in this article in no way represents investment adv... | |
| Goldman Sachs names 40 stocks to buy bef... | 04/11/21 |
| Summary List Placement Markets saw a strong start to the second quarter. The S&P 500 rose to a record high on April 1 and surpassed 4,000 points for t... | |
| Eli Lilly-Incyte's Baricitinib Study In ... | 04/08/21 |
| Eli Lilly And Co (NYSE: LLY ) and Incyte Corporation (NASDAQ: INCY ) have reported results from the COV-BARRIER Phase 3 study evaluating baricitinib p... | |
| Is Silicon Valley Replacing Big Pharma I... | 04/06/21 |
| The following article is sponsored by Mind Cure. The information contained in this article in no way represents investment advice or opinion on the pa... | |
| Fortress Biotech's Partner Firm Expands ... | 04/01/21 |
| Fortress Biotech Inc's (NASDAQ: FBIO ) partner company Journey Medical Corporation has agreed to acquire Qbrexza (glycopyrronium) in the U.S. from Der... | |
| Scientists are coming around to a surpri... | 03/29/21 |
| Summary List Placement In January, at the World Economic Forum's annual gathering of some of the globe's richest and most powerful leaders, Andrea Pfe... | |
| Pfizer And Eli Lilly's Osteoarthritis Dr... | 03/25/21 |
| An expert panel of the U.S. Food and Drug Administration has rejected Pfizer Inc . (NYSE: PFE ) and Eli Lilly and Company???s (NYSE: LLY ) application... | |
| US government stops distribution of Eli ... | 03/25/21 |
| The US government in coordination with Eli Lilly said it will no longer distribute the Covid-19 monoclonal antibody therapy bamlanivimab for use on it... | |
| Pfizer begins early-stage study of oral ... | 03/23/21 |
| Pfizer Inc has started an early-stage U.S. trial of an oral COVID-19 antiviral therapy that could be prescribed to patients at the first sign of infec... | |
| Autoinjectors Market Is Expected To Exhi... | 03/23/21 |
| Rise in anaphylaxis cases and increases in R&D activities by key players in the market are anticipated to drive the market. Rapid growth has been obse... | |
| Cleveland Clinic Collaborates with Lilly... | 03/23/21 |
| CLEVELAND, March 23, 2021 /PRNewswire/ -- Cleveland Clinic cardiac surgery expertise is now accessible to eligible Eli Lilly and Company employees, re... | |
| Booming CAGR of 14.4%, Monoclonal Antibo... | 03/23/21 |
| A new market study on the 2020-2027 Monoclonal Antibody Therapeutics Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pa... | |
| Pfizer/Eli Lilly's Tanezumab Safety Prof... | 03/22/21 |
| Ahead of an advisory committee meeting scheduled for later this week, the FDA released its in-depth review of Pfizer Inc (NYSE: PFE ) and Eli Lilly An... | |
| Barron's Latest Picks And Pans: Space Ra... | 03/21/21 |
| This weekend's Barron's cover story discusses ways to play the space race as the industry flourishes. Other featured articles offer sensible stocks fo... | |
| FDA Decisions For Pfizer, Eli Lilly And ... | 03/20/21 |
| Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market performance. Rubius Ther... | |
| Covid-19 Impact on Pharma & Cosmetics Ma... | 03/19/21 |
| Global Pharma & Cosmetics Market Synopsis: The exclusive research report on the Global Pharma & Cosmetics Market 2021-2025 examines the market in deta... | |
| Positive Phase 3 Efficacy Data Bolsters ... | 03/19/21 |
| The following article is sponsored by the clinical communications unit of Redington, Inc. which is paid by Tonix Pharmaceuticals Holding Corp. to prov... | |
| Elsevier Launches Updated Drug-Drug Inte... | 03/18/21 |
| NEW YORK, NY / ACCESSWIRE / March 18, 2021 / Calculator for predicting DDI risk enables rapid decision making and risk analysis to improve patient saf... | |
| Eli Lilly???s Covid-19 drug bamlanivimab... | 03/17/21 |
| The US government is no longer distributing Eli Lilly???s bamlanivimab into California, Arizona and Nevada because of the prevalence of a viral varian... | |
| Sglt2 Inhibitor Market Adoption of Advan... | 03/17/21 |
| Worldwide Market Reports adds "Sglt2 Inhibitor Market 2020 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2026" repo... | |
| This startup wants to use food as medici... | 03/16/21 |
| Summary List Placement Hello, Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news: The download on some mixed Alzhe... | |
| FDA requires Regeneron, Lilly to monitor... | 03/16/21 |
| As part of an effort to shore up public confidence in the FDA???s emergency use authorization processes, the agency on Monday released additional scie... | |
| Extended Stay, AMC rise; Eli Lilly, US S... | 03/15/21 |
| Stocks that traded heavily or had substantial price changes Monday: Extended Stay, AMC rise; Eli Lilly, United States Steel fall | |
| Stocks making the biggest moves in the p... | 03/15/21 |
| Take a look at some of the biggest movers in the premarket: GenMark Diagnostics (GNMK) ??? GenMark will be bought by Swiss drugmaker Roche for $1.8 bi... | |
| Stock Market Today With Jim Cramer: How ... | 03/15/21 |
| Jim Cramer discusses the latest stock market news including how to trade Eli Lilly after the update on their Alzheimer's trial, Tesla stock, and marke... | |
| Stocks making the biggest moves midday: ... | 03/15/21 |
| Check out the companies with notable stock price moves on Monday. | |
| Eli Lilly Stock Falls After Alzheimer's ... | 03/15/21 |
| Enthusiasm by the drugmaker for its antibody therapy had helped fuel investors' expectations, analysts say. | |
| Stocks making the biggest moves in the p... | 03/15/21 |
| The stocks making the biggest moves in premarket trading include GenMark Diagnostics, AMC Entertainment, Eli Lilly, and more. | |
| Caesars Entertainment, GenMark, Eli Lill... | 03/15/21 |
| Futures pointed to gains for major U.S. stock indexes. | |
| Alzheimer's Drug Discovery Foundation Co... | 03/13/21 |
| NEW YORK, March 13, 2021 /PRNewswire/ -- Eli Lilly and Company presented detailed results of its phase 2 TRAILBLAZER-ALZ study today, showing that its... | |
| Buy rating | 03/15/21 |
| Truist Securities maintains Buy rating and raises Price Target from $215.00 to $225.00 | |
| Strong Buy rating | 02/12/21 |
| Cowen & Co. maintains Outperform rating and raises Price Target from $195.00 to $235.00 | |
| Strong Buy rating | 02/04/21 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $190.00 to $217.00 | |
| Buy rating | 02/01/21 |
| Mizuho maintains Buy rating and raises Price Target from $222.00 to $228.00 | |
| Buy rating | 02/01/21 |
| Truist Securities maintains Buy rating and raises Price Target from $200.00 to $215.00 | |
| Buy rating | 01/22/21 |
| B of A Securities maintains Buy rating and raises Price Target from $195.00 to $225.00 | |
| Date | 2021-01-29 (BMO) | Est. (EPS/Rev.) | $2.35/ 7.29B |
| Actual (EPS/Rev.) | $2.75/ $7.44 B | EPS (TTM) | 6.05 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Portfolio | TraderCZ | 99.00 % | Subscribe |
| Options Eagle | George | 78.00 % | Follow |
| It's only money | Gavin wells | 58.00 % | Follow |
| Burdeshaw Investing | Matthew Burdeshaw | 56.00 % | Subscribe |
| Biotech picks | mr jackson | 50.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
